![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 31/135 | (2006.01) |
A61K 47/38 | (2006.01) | ||
A61P 37/06 | (2006.01) | ||
A61K 9/20 | (2006.01) | ||
A61K 9/48 | (2006.01) | ||
A61K 9/50 | (2006.01) | ||
A61K 9/28 | (2006.01) | ||
A61K 9/16 | (2006.01) |
(11) | Number of the document | 3103448 |
(13) | Kind of document | T |
(96) | European patent application number | 16176663.9 |
Date of filing the European patent application | 2007-09-25 | |
(97) | Date of publication of the European application | 2016-12-14 |
(45) | Date of publication and mention of the grant of the patent | 2019-07-03 |
(46) | Date of publication of the claims translation | 2019-10-10 |
(30) | Number | Date | Country code |
06121299 | 2006-09-26 | EP | |
06121301 | 2006-09-26 | EP | |
06121302 | 2006-09-26 | EP | |
06121276 | 2006-09-26 | EP |
(72) |
AMBÜHL, Michael, CH
BEYER, Jutta, CH
CARRENO-GOMEZ, Begona, CH
RUEGGER, Colleen, US
VALAZZA, Stephen, US
|
(73) |
NOVARTIS AG,
Lichtstrasse 35, 4056 Basel,
CH
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Farmacinės kompozicijos, apimančios S1P moduliatorių |
PHARMACEUTICAL COMPOSITIONS COMPRISING AN S1P MODULATOR |
Payment date | Validity (years) | Amount | |
2024-08-22 | 18 | 347.00 EUR |
2025-09-25 |